• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Three Clinical Markers Estimate Malignancy Probability Before Lung Cancer Bronchoscopy

by
November 21, 2026
in Cancer, Health
Reading Time: 4 mins read
0
Three Clinical Markers Estimate Malignancy Probability Before Lung Cancer Bronchoscopy

Three Clinical Markers Estimate Malignancy Probability Before Lung Cancer Bronchoscopy

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A retrospective cohort study of 336 patients undergoing clinical evaluation for suspected lung cancer has developed a simplified risk stratification nomogram to estimate malignancy probability prior to bronchoscopy. Conducted by investigators at the First Affiliated Hospital of Fujian Medical University, the research identified three routinely accessible clinical variables—patient age, smoking status, and circulating serum carcinoembryonic antigen levels—that independently correlate with confirmed malignant disease. By synthesizing these standard clinical indicators into a multivariable predictive instrument, the investigators aimed to provide a practical bedside tool for assessing individual pre-procedure malignancy likelihood in individuals who are already being considered for diagnostic bronchoscopic intervention.

Bronchoscopy plays a foundational role in the conventional diagnostic evaluation of suspected pulmonary neoplasms, yet clinicians frequently lack simple, objective instruments to quantify malignancy risk before undertaking invasive procedures. While several predictive scoring systems currently exist, most published risk models were engineered primarily to estimate the malignant potential of incidental pulmonary nodules. Consequently, existing frameworks rely extensively on advanced radiological features and detailed imaging characteristics, which often restricts their direct applicability to the immediate pre-bronchoscopy setting where procedural prioritization and timely clinical scheduling decisions must be made using standard clinical data.

To establish a focused scoring system, the study investigators initially evaluated 32 candidate predictors restricted entirely to clinical variables that are routinely documented prior to bronchoscopy. Predictors were selected according to predefined criteria emphasizing clinical relevance, everyday availability, and high data completeness across the retrospective cohort. The researchers then applied least absolute shrinkage and selection operator regression to minimize overfitting and reduce data dimensionality, retaining 18 candidate variables from the original set. These 18 variables were subsequently incorporated into a multivariable logistic regression framework, after which further elimination was executed based on formal statistical criteria and clinical judgment to generate the final simplified nomogram.

The resulting multivariable logistic regression analysis established three independent predictors of malignancy within the cohort: advancing age, smoking history, and elevated serum carcinoembryonic antigen concentrations. Each additional year of age was associated with an odds ratio of 1.045 for malignant disease (95 percent confidence interval: 1.017 to 1.073, P < 0.001). Smoking status imparted a substantial increase in risk, demonstrating an odds ratio of 3.216 (95 percent confidence interval: 1.847 to 5.598, P < 0.001). Log-transformed serum carcinoembryonic antigen levels, evaluated per unit increase of ln(CEA + 1), exhibited the strongest association with malignancy, yielding an odds ratio of 4.989 (95 percent confidence interval: 3.095 to 8.043, P < 0.001).

Model performance was evaluated across the full retrospective cohort and subjected to internal validation utilizing a bootstrap resampling procedure with 1,000 resamples. After bootstrap optimism correction, the simplified risk prediction nomogram achieved a corrected concordance statistic of 0.837, indicating acceptable discriminative capacity between malignant and non-malignant cases. The corresponding calibration slope was 0.972, demonstrating close alignment between predicted probabilities and observed clinical outcomes across the study population. The authors noted as a methodological detail that the post-LASSO variable elimination steps were not repeated within the individual bootstrap resamples during the internal validation protocol.

In dedicated biomarker analyses, the researchers evaluated the diagnostic sensitivity and specificity of carcinoembryonic antigen measured across distinct biological compartments. At an identified cut-off threshold of 4.57 nanograms per milliliter, serum carcinoembryonic antigen demonstrated high diagnostic specificity of 94 percent, balanced by a moderate sensitivity of 52 percent. Conversely, testing carcinoembryonic antigen within bronchoalveolar lavage fluid at a diagnostic threshold of 22.6 nanograms per milliliter yielded higher sensitivity at 71 percent, accompanied by a lower diagnostic specificity of 57 percent. Restricted cubic spline modeling confirmed that the association between circulating serum carcinoembryonic antigen concentrations and lung cancer risk remained linear throughout the observed range, with no evidence of non-linearity (P = 0.514).

The investigators also conducted a formal mediation analysis to explore the biological relationship connecting tobacco consumption, circulating tumor marker elevations, and cancer diagnosis. The mediation model indicated that serum carcinoembryonic antigen levels partially mediate the epidemiological association observed between cigarette smoking and lung cancer, yielding a statistically significant indirect effect of 0.09 (95 percent confidence interval: 0.02 to 0.15, P = 0.004). This analytical finding illustrates that part of the observed relationship between smoking status and malignant disease is statistically explained through the intermediate elevation of circulating carcinoembryonic antigen concentrations within this patient cohort.

The authors stressed that the newly developed nomogram is strictly intended as an adjunctive risk stratification instrument to estimate malignancy probability within a selected pre-bronchoscopy population, rather than a definitive test to establish procedural appropriateness or delineate an optimal diagnostic pathway. Because the study was based on a single-center retrospective sample of 336 patients relative to 32 candidate predictors, the investigators explicitly cautioned that the model remains exploratory and supportive rather than determinative. The authors concluded that extensive external validation in larger, geographically diverse patient populations is essential before the simplified clinical scoring tool can be considered for formal clinical implementation.

Subject of Research: Pre-bronchoscopy risk stratification for suspected lung cancer using clinical variables

Article Title: A simplified pre-bronchoscopy risk stratification model for patients with suspected lung cancer based on age, smoking status, and serum CEA

Article References: Wang, S., Lin, G., Huang, J., Fu, L., Chen, Y., Zeng, A., & Wang, B. (2026). A simplified pre-bronchoscopy risk stratification model for patients with suspected lung cancer based on age, smoking status, and serum CEA. Frontiers in Oncology, 16, Article 1919825. https://doi.org/10.3389/fonc.2026.1919825

Image Credits: AI Generated

DOI: 10.3389/fonc.2026.1919825

Keywords: bronchoscopy, lung cancer, risk stratification, carcinoembryonic antigen, serum CEA, smoking status, nomogram, prediction model, bootstrap internal validation, logistic regression, LASSO regression, bronchoalveolar lavage fluid, BALF CEA, clinical prioritization, thoracic oncology, restricted cubic spline, mediation analysis

News Source: Nathaniel Bowman. (November 21, 2026). Three Clinical Markers Estimate Malignancy Probability Before Lung Cancer Bronchoscopy. Scienmag.

Tags: BALF CEAbootstrap internal validationbronchoalveolar lavage fluidbronchoscopyCarcinoembryonic Antigenclinical prioritizationLASSO regressionlogistic regressionlung cancermediation analysisnomogramprediction modelrestricted cubic splinerisk stratificationserum CEAsmoking statusthoracic oncology
Share12Tweet7Share2ShareShareShare1

Related Posts

Review Assesses Skin Reactions Across Modern Diabetes and Obesity Therapies

Review Assesses Skin Reactions Across Modern Diabetes and Obesity Therapies

November 22, 2026
Hemodialysis Frailty Profiles Show No Significant Link to Hospitalization After Adjustment

Hemodialysis Frailty Profiles Show No Significant Link to Hospitalization After Adjustment

November 22, 2026

Rare Neural Autoantibodies Identified in Cerebrospinal Fluid in Schizophrenia Spectrum Disorders

November 22, 2026

Pyrogallic Acid Restores Doxycycline Susceptibility in Multidrug-Resistant Enterotoxigenic Escherichia Coli

November 22, 2026

POPULAR NEWS

  • LLM-Enhanced BERTopic Improves Topic Coherence and Diversity in Specialized Tourism Corpus

    LLM-Enhanced BERTopic Improves Topic Coherence and Diversity in Specialized Tourism Corpus

    29 shares
    Share 12 Tweet 7
  • Hemodialysis Frailty Profiles Show No Significant Link to Hospitalization After Adjustment

    29 shares
    Share 12 Tweet 7
  • Rare Neural Autoantibodies Identified in Cerebrospinal Fluid in Schizophrenia Spectrum Disorders

    29 shares
    Share 12 Tweet 7
  • Pyrogallic Acid Restores Doxycycline Susceptibility in Multidrug-Resistant Enterotoxigenic Escherichia Coli

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Review Assesses Skin Reactions Across Modern Diabetes and Obesity Therapies

LLM-Enhanced BERTopic Improves Topic Coherence and Diversity in Specialized Tourism Corpus

Hemodialysis Frailty Profiles Show No Significant Link to Hospitalization After Adjustment

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.